CMG PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,120 KRW | 0.00% |
|
+0.24% | -12.03% |
ETFs positioned on CMG Pharmaceutical Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 7 M€ | +6.58% | - |
CMG Pharmaceutical Co., Ltd is a Korea-based company specialized in the manufacture of pharmaceuticals. The Companyâs products include antibiotics, antifungals, antivirus, anti-tuberculousis drugs, peptic ulcer drugs, dementia remedies, antihistamines and antipyretics, among others. It is also engaged in the manufacture of stone products. The Company mainly distributes is pharmaceutical products within domestic markets, as well as to overseas markets. On April 16, 2013, the Company changed its name from SKYNEWPHARM. Co., Ltd to CMG Pharmaceutical Co., Ltd.
Sector
Pharmaceuticals
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -12.03% | 218M | |
| +21.63% | 44.12B | |
| +22.99% | 22.71B | |
| +18.22% | 15.15B | |
| +12.66% | 13.61B | |
| +60.18% | 13.34B | |
| -8.35% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.92% | 5.63B |
- Stock Market
- Equities
- A058820 Stock
- Funds and ETFs CMG Pharmaceutical Co., Ltd.
